ER Positive Breast Cancer: 247 Real Stories

247 stories match breast cancer and ER positive. 215 of them mention surgery.

Cancer Stories

Kate, who was diagnosed with Stage IV Breast CancerBreast Cancer

Kate's Story: How I Lean Into Every Day With MBC

Patient Info: Kate | Stage IV

Biomarkers: ER-positive, HER2-negative

Metastatic Site: liver

7+ years living with de novo metastatic ER-positive, HER2-negative breast cancer with liver metastases while remaining on first-line palbociclib and letrozole.

breastcancer.org
OutcomeLiving With Cancer
DivineMrsM, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: DivineMrsM's Patient Story

Patient Info: DivineMrsM, Female | Stage IV

Biomarkers: ER-positive, HER2-negative

Living with stable Stage IV ER-positive, HER2-negative breast cancer almost 4 years after diagnosis while taking daily Arimidex.

breastcancer.org
OutcomeStable Disease
Susan, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Susan's Patient Story

Patient Info: Susan, Female | Stage I

Biomarkers: ER 100% positive; HER2-negative; progesterone receptor result not reported; multigene testing pending

Susan had completed breast surgery for a small early-stage invasive ductal cancer and was awaiting final pathology and genetic results to determine whether radiation, chemotherapy, and long-term endocrine therapy would be needed.

breastcancer.org
OutcomeCare Ongoing
Ann, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Ann's Patient Story

Patient Info: Ann, Female | Stage IV

Biomarkers: ER-positive; HER2-negative

Metastatic Site: peritoneum; intestines/bowel

Ann was living with metastatic invasive lobular breast cancer involving the peritoneum and bowel. After 9 months of recurrence treatment, she underwent successful ileostomy reversal and regained greater freedom to travel.

breastcancer.org
OutcomeLiving With Cancer
Jenna, who was diagnosed with Breast CancerBreast Cancer

HR-Positive Breast Cancer: Jenna's Patient Story

Patient Info: Jenna, Female, Under 40

Biomarkers: ER-positive

Jenna completed 10 rounds of chemotherapy and double mastectomy for ER-positive breast cancer with lymph-node involvement. She was recovering, planning reconstruction, and preparing for long-term tamoxifen.

breastcancer.org
OutcomeCare Ongoing
Amy, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Amy's Patient Story

Patient Info: Amy, Female, 40s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative; BRCA1/2 negative

Metastatic Site: bones

Amy learned within weeks of bilateral mastectomy that invasive lobular breast cancer had involved lymph nodes and spread to her bones, changing her diagnosis from Stage I to Stage IV.

breastcancer.org
OutcomeLiving With Cancer
Tanya, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II HR-Positive Invasive Lobular Carcinoma: Tanya's Patient Story

Patient Info: Tanya, Female, 40s | Stage II

Biomarkers: Genetic testing negative; Oncotype DX score 27; MammaPrint low risk; ER-positive

Tanya had Stage II ER-positive breast cancer with a large lobular tumor found on MRI, underwent bilateral mastectomy with immediate reconstruction, completed 4 rounds of chemotherapy, and started tamoxifen.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
Nikoo, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Nikoo's Patient Story

Patient Info: Nikoo, Female | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative

Metastatic Site: Peritoneum | Ascites | Possible bone

Nikoo’s early lobular breast cancer treated in 2003 with lumpectomy, radiation, and 5 years of tamoxifen recurred 19 years later as ER-positive, PR-positive, HER2-negative metastatic lobular breast cancer involving the peritoneum, ascites, and possible bone.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Jeri, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Jeri's Patient Story

Patient Info: Jeri, Female, 60s | Stage IV

Biomarkers: ER-positive; PR-negative; HER2-negative

Metastatic Site: Lymph node | Ovaries | Fallopian tubes | Uterus | Bone

Jeri was diagnosed with de novo Stage IV ER-positive, PR-negative, HER2-negative ILC involving lymph node, gynecologic organs, and bone; after progression on 2 estrogen-therapy-based combinations, a different drug stabilized the disease 10 months after diagnosis.

Lobular Breast Cancer Alliance
OutcomeResponding Well
Leanne, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Leanne's Patient Story

Patient Info: Leanne, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-positive

Metastatic Site: Brain

Leanne was first diagnosed in 2015 with Stage III triple-positive ILC and then diagnosed with metastatic lobular breast cancer with brain metastasis on April 4, 2018, causing major neurologic and work limitations.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Robbie, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Robbie's Patient Story

Patient Info: Robbie, Female | Stage IV

Biomarkers: Estrogen receptor-positive / ER-positive

Metastatic Site: Bone; liver

Living with metastatic breast cancer involving bone and liver after earlier DCIS and Stage II ER-positive breast cancer; ongoing treatment at Mass General focused on stabilization and long-term disease management.

Massachusetts General Hospital
OutcomeLiving With Cancer
Eutha, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Radiation-related morphea years after breast cancer treatment

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative

At follow-up in March 2026, more than 10 years after her breast cancer diagnosis, she remained free of oncologic recurrence and had completed 10 years of tamoxifen.

PubMed Central
OutcomeCancer-Free / NED
Alison, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Alison's Survivor Story

Patient Info: Alison, Female, Under 40 | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-positive

Metastatic Site: Cervical/neck lymph nodes

Alison reported complete remission since August 2017 while continuing intermittent maintenance chemotherapy, most recently 1 month of treatment followed by 2 months off.

The Patient Story
OutcomeLiving With Cancer / Remission
Stefanie, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Stage III HR-Positive Invasive Ductal Carcinoma: Stefanie's Survivor Story

Patient Info: Stefanie, Female | Stage III

Biomarkers: ER-positive, PR-positive and HER2-positive

Stefanie completed chemotherapy, breast-conserving surgery, prolonged Herceptin and 30 radiation treatments, then moved into survivorship while still adjusting to the lasting effects of treatment.

The Patient Story
OutcomeTreatment Completed / Survivorship
Shari, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Ductal Carcinoma: Shari's Patient Story

Patient Info: Shari S., Female | Stage IV

Biomarkers: ER-positive, PR-positive and HER2-positive; no inherited cancer mutation was identified

Metastatic Site: Brain; other initial metastatic sites were not named

Systemic imaging after chemotherapy showed no active disease, but brain metastases later required stereotactic radiation. Shari remained stage 4, continued Herceptin every 3 weeks and underwent brain MRI every 3–4 months.

The Patient Story
OutcomeLiving With Cancer / Ongoing Therapy
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Hidden metastatic breast cancer found in bone marrow during blood-cancer monitoring

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: ER-positive

Metastatic Site: bone marrow, bone

More than 7 years after metastatic breast carcinoma was first identified in 2018, she had stable skeletal disease and ongoing biochemical improvement on palbociclib plus fulvestrant in March 2026.

PubMed Central
OutcomeStable Disease
A patient, who was diagnosed with Breast CancerBreast Cancer

Breast cancer treatment in a woman with mirror-image organ anatomy

Patient Info: Anonymized, Female

Biomarkers: ER-positive; HER2-negative

A woman in her early 60s with mirror-image organ anatomy received chemotherapy and mastectomy for left breast cancer after a specially planned venous port placement.

PubMed Central
OutcomeNot reported
SI
Breast Cancer

Stage I HR-Positive Breast Cancer: Dina's Patient Story

Patient Info: Dina, Female | Stage I

Biomarkers: ER-positive; PR-positive

As of June 2026, Dina was newly navigating Stage I ER/PR-positive breast cancer after biopsy confirmation, with the story focused on diagnosis, decision-making, and support from her fiancé Caleb.

Susan G. Komen
OutcomeCare Ongoing
Doreen, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Doreen's Patient Story

Patient Info: Doreen, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Doreen had completed TCHP chemotherapy with a complete response before surgery and had undergone lumpectomy and radiation for Stage IIA triple-positive breast cancer.

The Patient Story
OutcomeResponding Well
Callie, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Callie's Survivor Story

Patient Info: Callie, Female, Under 40 | Stage II

Biomarkers: ER-positive

As of June 2026, Callie described survivorship after mastectomy, ACT chemotherapy, reconstruction, and hysterectomy for Stage IIB ER-positive IDC, with all cancer-directed treatment completed by the end of 2019.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Rach, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II HR-Positive Breast Cancer: Rach's Patient Story

Patient Info: Rach D., Female, Under 40 | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Rach described Stage II triple-positive breast cancer treated with fertility preservation, 6 rounds of neoadjuvant TCHP including Herceptin, Zoladex ovarian suppression, and double mastectomy with reconstruction.

The Patient Story
OutcomeCare Ongoing